Thompson Siegel & Walmsley LLC Has $6.04 Million Stake in CVS Health Co. (NYSE:CVS)

Thompson Siegel & Walmsley LLC lowered its stake in CVS Health Co. (NYSE:CVS) by 19.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 95,986 shares of the pharmacy operator’s stock after selling 23,277 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in CVS Health were worth $6,036,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in CVS. Pzena Investment Management LLC increased its holdings in shares of CVS Health by 1.5% during the third quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator’s stock worth $825,948,000 after purchasing an additional 198,920 shares during the period. Lazard Asset Management LLC increased its holdings in CVS Health by 5.9% in the 1st quarter. Lazard Asset Management LLC now owns 6,963,508 shares of the pharmacy operator’s stock worth $555,406,000 after purchasing an additional 389,166 shares in the last quarter. AQR Capital Management LLC boosted its position in CVS Health by 33.5% during the 2nd quarter. AQR Capital Management LLC now owns 5,289,788 shares of the pharmacy operator’s stock worth $310,722,000 after buying an additional 1,327,855 shares during the period. National Pension Service lifted its holdings in shares of CVS Health by 17.4% during the third quarter. National Pension Service now owns 2,843,402 shares of the pharmacy operator’s stock worth $178,793,000 after purchasing an additional 421,416 shares during the period. Finally, Bank of Montreal Can grew its position in shares of CVS Health by 2.4% in the 2nd quarter. Bank of Montreal Can now owns 2,436,343 shares of the pharmacy operator’s stock valued at $143,890,000 after buying an additional 57,214 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CVS has been the subject of several recent analyst reports. Barclays decreased their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Mizuho reduced their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Evercore ISI upped their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. UBS Group increased their price objective on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Finally, Royal Bank of Canada decreased their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $72.28.

CVS Health Stock Up 0.4 %

Shares of CVS Health stock opened at $57.07 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market cap of $71.81 billion, a P/E ratio of 14.48, a PEG ratio of 0.94 and a beta of 0.55. The firm’s 50 day moving average price is $59.20 and its 200-day moving average price is $58.60. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.21 earnings per share. On average, sell-side analysts predict that CVS Health Co. will post 5.43 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.66%. CVS Health’s payout ratio is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.